Zimbabwe has declined a major US health deal worth $367m (£272m) spanning five years over Washington's demand for sensitive data.
The decision became public after a official document dated December was disclosed, which showed President Emmerson Mnangagwa felt the agreement was "lopsided".
A government spokesman later stated that the US was demanding access to health data for scientific study and profit but was unwilling to share the resulting advantages from any future vaccines.
"We are forced to start the challenging and unfortunate process of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had donated over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for further negotiations to secure a agreement suitable to all parties so the country's critical HIV treatment initiative can proceed.
Wider Background
Zimbabwe's decision follows a similar case in Kenya, where a high court blocked a related deal with the US following legal challenges were raised about the security of Kenyans' health data.
After resuming the presidency recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government deals to enhance openness and accountability.
According to statements, Sixteen nations in Africa have so far signed these new agreements, constituting over $18.3bn in committed funds.
Details of the Rejected Agreement
The money for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment via American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information indefinitely, with no corresponding promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"Effectively, our country would provide the raw materials for medical research without any assurance that the final treatments would be available to our population should a future pandemic emerge."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its push of one-on-one deals were undermining structures previously established through the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future global health emergencies.
"This framework is intended to ensure that when a country contributes its samples, the resulting advantages – including medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to create them."
The government's concerns over the US deal "are not meant as hostility towards the US," he added.
"We encourage continued dialogue with our American counterparts on how subsequent co-operation could be structured in a way that respects the sovereignty and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but recommended that talks should continue given that much of the country's HIV programmes depended on international support.
"In cases where technical issues exist, including those involving data governance or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," it said.
This impasse emphasises the complex challenges between receiving vital foreign assistance and safeguarding a country's data in an increasingly interconnected world.